Vaughan & CO Securities, Inc. Bristol Myers Squibb CO Transaction History
Vaughan & CO Securities, Inc.
- $171 Million
- Q2 2025
A detailed history of Vaughan & CO Securities, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vaughan & CO Securities, Inc. holds 11,684 shares of BMY stock, worth $523,676. This represents 0.32% of its overall portfolio holdings.
Number of Shares
11,684
Previous 11,706
0.19%
Holding current value
$523,676
Previous $713,000
24.26%
% of portfolio
0.32%
Previous 0.45%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.58 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.11 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.84 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.25 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$2.98 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $95.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...